Skip to main content
letter
. 2002 Apr;70(4):1069–1071. doi: 10.1086/339466

Table 1.

Sex of Offspring of Cancer Survivors (Stratified by Type of Treatment Received) and of Sibling Controls

No. of Offspring ofSurvivors Who Receiveda,b
No. of Offspring ofSurvivors Who Receivedc
Sex of OffspringStratified bySex of Subjects PotentiallyMutagenicTherapy Less- orNonmutagenicTherapy No. of Offspring of Sibling Controlsb PotentiallyMutagenicTherapy Less- orNonmutagenicTherapy
Male subjects:
 Male offspring 100 344 1,022 137 529
 Female offspring 94
340
1,021
141
522
  Subtotal (sex ratio) 194 (1.06) 684 (1.01) 2,043 (1.00) 278 (0.97) 1,051 (1.01)
Female subjects:
 Male offspring 98 513 1,278 140 794
 Female offspring 116
498
1,223
165
731
  Subtotal (sex ratio) 214 (0.84)
1,011 (1.03)
2,501 (1.04)
305 (0.85)
1,525 (1.09)
   Total 408 1,695 4,544 583 2,576
a

The sum of offspring of survivors treated with potentially mutagenic therapy and those treated with less- or nonmutagenic therapy is slightly less than the total number of offspring of the survivors, because the site of radiotherapy, in some patients, was not known.

b

Data on offspring of subjects from original study (Byrne et al. 1998).

c

Combined data (Hawkins 1991; Byrne et al. 1998).